21 C.F.R. § 556.735

Tilmicosin.

Last amended: 2019Year: 2026Length: 79 wordsSubsections: 4Official source

Cite as 21 C.F.R. § 556.735 (2026)

(a) Acceptable daily intake (ADI). The ADI for total residue of tilmicosin is 25 µg/kg of body weight per day. (b) Tolerances. The tolerances for tilmicosin (marker residue) are: (1) Cattle. (i) Liver (target tissue): 1.2 ppm. (ii) Muscle: 0.1 ppm. (2) Sheep. (i) Liver (target tissue): 1.2 ppm. (ii) Muscle: 0.1 ppm. (3) Swine. (i) Liver (target tissue): 7.5 ppm. (ii) Muscle: 0.1 ppm. (c) Related conditions of use. See §§ 520.2471, 522.2471, and 558.618 of this chapter.
Cross-references to the CFR
520.2471
21 C.F.R. § 556.735: Tilmicosin. | Justis AI